Procardia and Hepatocellular damage aggravated - a phase IV clinical study of FDA data

Summary:

Hepatocellular damage aggravated is reported as a side effect among people who take Procardia (nifedipine), especially for people who are male, 60+ old, also take Lasix, and have Pulmonary hypertension.

The phase IV clinical study analyzes which people have Hepatocellular damage aggravated when taking Procardia. It is created by eHealthMe based on reports of 14,828 people who have side effects when taking Procardia from the FDA, and is updated regularly.

What is Procardia?

Procardia has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 15,151 Procardia users. Check the latest studies of Procardia.

What is Hepatocellular damage aggravated?

Hepatocellular damage aggravated (serious liver damage) is found to be associated with 501 drugs and 192 conditions by eHealthMe. Check the latest studies of Hepatocellular damage aggravated.

On Jul, 10, 2026

14,828 people reported to have side effects when taking Procardia.
Among them, 16 people (0.11%) have Hepatocellular damage aggravated.

Could Procardia cause Hepatocellular damage aggravated?

Among these 16 people:

What is the gender of people who have Hepatocellular damage aggravated when taking Procardia? *

female: 50 %
male: 50 %

What is the age of people who have Hepatocellular damage aggravated when taking Procardia? *

What are other drugs people take besides Procardia? *

What are other side effects people have besides Hepatocellular damage aggravated? *

Hepatomegaly (abnormal enlargement of the liver): 3 people, 18.75%
Hepatitis (inflammation of the liver): 3 people, 18.75%
Atrioventricular Block Complete (heart block complete): 3 people, 18.75%
Arrhythmias (irregular heartbeat): 3 people, 18.75%
High Blood Cholesterol: 3 people, 18.75%
Nausea (feeling of having an urge to vomit): 2 people, 12.50%
Hyperthermia Malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions): 2 people, 12.50%
Cardiac Arrest: 2 people, 12.50%
Diabetes Mellitus Aggravated (serious diabetes): 2 people, 12.50%
Cardiogenic Shock (inadequate circulation of blood): 2 people, 12.50%

What are the existing conditions these people have? *

Type 2 Diabetes: 1 person, 6.25%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 6.25%
Sedation: 1 person, 6.25%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Procardia and have Hepatocellular damage aggravated?

- Check whether Hepatocellular damage aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Procardia:

Procardia (15,151 reports)

Browse all side effects of Procardia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatocellular damage aggravated:

Hepatocellular damage aggravated (501 drugs)

Browse all the conditions that are associated with Hepatocellular damage aggravated:

Hepatocellular damage aggravated (192 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Procardia) and Procardia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.